 | • レポートコード：MRC2012B1288 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、短腸症候群（SBS）の世界市場を広く調査・分析し、今後の市場展望をまとめております。短腸症候群（SBS）の種類別市場規模（経口ルート、非経口ルート）、用途別市場規模（病院、診療所、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Sancilio Pharmaceuticals、Ardelyx、Takeda、OxThera、Emmaus Medical、Nutrinia、Naia Pharmaceuticals、Zealand Pharma、 ・地域別グローバル市場分析 2015年-2020年 ・短腸症候群（SBS）の北米市場（アメリカ、カナダ、メキシコ） ・短腸症候群（SBS）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・短腸症候群（SBS）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・短腸症候群（SBS）の南米市場（ブラジル、アルゼンチン） ・短腸症候群（SBS）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口ルート、非経口ルート ・用途別分析：病院、診療所、小売薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Short Bowel Syndrome (SBS) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Short Bowel Syndrome (SBS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Short Bowel Syndrome (SBS) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Short Bowel Syndrome (SBS) market has been segmented into:
Oral Route
Parental Route
By Application, Short Bowel Syndrome (SBS) has been segmented into:
Hospitals
Clinics
Retail Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Short Bowel Syndrome (SBS) market presented in the report. This section sheds light on the sales growth of different regional and country-level Short Bowel Syndrome (SBS) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Short Bowel Syndrome (SBS) market.
The report offers in-depth assessment of the growth and other aspects of the Short Bowel Syndrome (SBS) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Short Bowel Syndrome (SBS) Market Share Analysis
Short Bowel Syndrome (SBS) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Short Bowel Syndrome (SBS) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Short Bowel Syndrome (SBS) sales, revenue and market share for each player covered in this report.
The major players covered in Short Bowel Syndrome (SBS) are:
Merck
Sancilio Pharmaceuticals
Ardelyx
Takeda
OxThera
Emmaus Medical
Nutrinia
Naia Pharmaceuticals
Zealand Pharma
Table of Contents
1 Short Bowel Syndrome (SBS) Market Overview
1.1 Product Overview and Scope of Short Bowel Syndrome (SBS)
1.2 Classification of Short Bowel Syndrome (SBS) by Type
1.2.1 Global Short Bowel Syndrome (SBS) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Short Bowel Syndrome (SBS) Revenue Market Share by Type in 2019
1.2.3 Oral Route
1.2.4 Parental Route
1.3 Global Short Bowel Syndrome (SBS) Market by Application
1.3.1 Overview: Global Short Bowel Syndrome (SBS) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Global Short Bowel Syndrome (SBS) Market by Regions
1.4.1 Global Short Bowel Syndrome (SBS) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Short Bowel Syndrome (SBS) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Short Bowel Syndrome (SBS) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Short Bowel Syndrome (SBS) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Short Bowel Syndrome (SBS) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Short Bowel Syndrome (SBS) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Short Bowel Syndrome (SBS) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sancilio Pharmaceuticals
2.2.1 Sancilio Pharmaceuticals Details
2.2.2 Sancilio Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sancilio Pharmaceuticals SWOT Analysis
2.2.4 Sancilio Pharmaceuticals Product and Services
2.2.5 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ardelyx
2.3.1 Ardelyx Details
2.3.2 Ardelyx Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ardelyx SWOT Analysis
2.3.4 Ardelyx Product and Services
2.3.5 Ardelyx Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Takeda SWOT Analysis
2.4.4 Takeda Product and Services
2.4.5 Takeda Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2018-2019)
2.5 OxThera
2.5.1 OxThera Details
2.5.2 OxThera Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 OxThera SWOT Analysis
2.5.4 OxThera Product and Services
2.5.5 OxThera Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Emmaus Medical
2.6.1 Emmaus Medical Details
2.6.2 Emmaus Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Emmaus Medical SWOT Analysis
2.6.4 Emmaus Medical Product and Services
2.6.5 Emmaus Medical Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Nutrinia
2.7.1 Nutrinia Details
2.7.2 Nutrinia Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Nutrinia SWOT Analysis
2.7.4 Nutrinia Product and Services
2.7.5 Nutrinia Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Naia Pharmaceuticals
2.8.1 Naia Pharmaceuticals Details
2.8.2 Naia Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Naia Pharmaceuticals SWOT Analysis
2.8.4 Naia Pharmaceuticals Product and Services
2.8.5 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2018-2019)
2.9 Zealand Pharma
2.9.1 Zealand Pharma Details
2.9.2 Zealand Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Zealand Pharma SWOT Analysis
2.9.4 Zealand Pharma Product and Services
2.9.5 Zealand Pharma Short Bowel Syndrome (SBS) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Short Bowel Syndrome (SBS) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Short Bowel Syndrome (SBS) Players Market Share
3.2.2 Top 10 Short Bowel Syndrome (SBS) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Short Bowel Syndrome (SBS) Revenue and Market Share by Regions
4.2 North America Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
4.3 Europe Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
4.5 South America Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
5 North America Short Bowel Syndrome (SBS) Revenue by Countries
5.1 North America Short Bowel Syndrome (SBS) Revenue by Countries (2015-2020)
5.2 USA Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
5.3 Canada Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
5.4 Mexico Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
6 Europe Short Bowel Syndrome (SBS) Revenue by Countries
6.1 Europe Short Bowel Syndrome (SBS) Revenue by Countries (2015-2020)
6.2 Germany Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
6.3 UK Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
6.4 France Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
6.5 Russia Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
6.6 Italy Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Short Bowel Syndrome (SBS) Revenue by Countries
7.1 Asia-Pacific Short Bowel Syndrome (SBS) Revenue by Countries (2015-2020)
7.2 China Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
7.3 Japan Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
7.4 Korea Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
7.5 India Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
8 South America Short Bowel Syndrome (SBS) Revenue by Countries
8.1 South America Short Bowel Syndrome (SBS) Revenue by Countries (2015-2020)
8.2 Brazil Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
8.3 Argentina Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Short Bowel Syndrome (SBS) by Countries
9.1 Middle East & Africa Short Bowel Syndrome (SBS) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
9.3 UAE Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
9.4 Egypt Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
9.5 South Africa Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Short Bowel Syndrome (SBS) Revenue and Market Share by Type (2015-2020)
10.2 Global Short Bowel Syndrome (SBS) Market Forecast by Type (2019-2024)
10.3 Oral Route Revenue Growth Rate (2015-2025)
10.4 Parental Route Revenue Growth Rate (2015-2025)
11 Global Short Bowel Syndrome (SBS) Market Segment by Application
11.1 Global Short Bowel Syndrome (SBS) Revenue Market Share by Application (2015-2020)
11.2 Short Bowel Syndrome (SBS) Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Retail Pharmacies Revenue Growth (2015-2020)
12 Global Short Bowel Syndrome (SBS) Market Size Forecast (2021-2025)
12.1 Global Short Bowel Syndrome (SBS) Market Size Forecast (2021-2025)
12.2 Global Short Bowel Syndrome (SBS) Market Forecast by Regions (2021-2025)
12.3 North America Short Bowel Syndrome (SBS) Revenue Market Forecast (2021-2025)
12.4 Europe Short Bowel Syndrome (SBS) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Short Bowel Syndrome (SBS) Revenue Market Forecast (2021-2025)
12.6 South America Short Bowel Syndrome (SBS) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Short Bowel Syndrome (SBS) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Short Bowel Syndrome (SBS) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Short Bowel Syndrome (SBS) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Short Bowel Syndrome (SBS) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Short Bowel Syndrome (SBS) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Merck Corporate Information, Location and Competitors
Table 6. Merck Short Bowel Syndrome (SBS) Major Business
Table 7. Merck Short Bowel Syndrome (SBS) Total Revenue (USD Million) (2017-2018)
Table 8. Merck SWOT Analysis
Table 9. Merck Short Bowel Syndrome (SBS) Product and Solutions
Table 10. Merck Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sancilio Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Major Business
Table 13. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Total Revenue (USD Million) (2018-2019)
Table 14. Sancilio Pharmaceuticals SWOT Analysis
Table 15. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Product and Solutions
Table 16. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Ardelyx Corporate Information, Location and Competitors
Table 18. Ardelyx Short Bowel Syndrome (SBS) Major Business
Table 19. Ardelyx Short Bowel Syndrome (SBS) Total Revenue (USD Million) (2017-2018)
Table 20. Ardelyx SWOT Analysis
Table 21. Ardelyx Short Bowel Syndrome (SBS) Product and Solutions
Table 22. Ardelyx Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Takeda Corporate Information, Location and Competitors
Table 24. Takeda Short Bowel Syndrome (SBS) Major Business
Table 25. Takeda Short Bowel Syndrome (SBS) Total Revenue (USD Million) (2017-2018)
Table 26. Takeda SWOT Analysis
Table 27. Takeda Short Bowel Syndrome (SBS) Product and Solutions
Table 28. Takeda Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. OxThera Corporate Information, Location and Competitors
Table 30. OxThera Short Bowel Syndrome (SBS) Major Business
Table 31. OxThera Short Bowel Syndrome (SBS) Total Revenue (USD Million) (2017-2018)
Table 32. OxThera SWOT Analysis
Table 33. OxThera Short Bowel Syndrome (SBS) Product and Solutions
Table 34. OxThera Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Emmaus Medical Corporate Information, Location and Competitors
Table 36. Emmaus Medical Short Bowel Syndrome (SBS) Major Business
Table 37. Emmaus Medical Short Bowel Syndrome (SBS) Total Revenue (USD Million) (2017-2018)
Table 38. Emmaus Medical SWOT Analysis
Table 39. Emmaus Medical Short Bowel Syndrome (SBS) Product and Solutions
Table 40. Emmaus Medical Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Nutrinia Corporate Information, Location and Competitors
Table 42. Nutrinia Short Bowel Syndrome (SBS) Major Business
Table 43. Nutrinia Short Bowel Syndrome (SBS) Total Revenue (USD Million) (2017-2018)
Table 44. Nutrinia SWOT Analysis
Table 45. Nutrinia Short Bowel Syndrome (SBS) Product and Solutions
Table 46. Nutrinia Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Naia Pharmaceuticals Corporate Information, Location and Competitors
Table 48. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Major Business
Table 49. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Total Revenue (USD Million) (2017-2018)
Table 50. Naia Pharmaceuticals SWOT Analysis
Table 51. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Product and Solutions
Table 52. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Zealand Pharma Corporate Information, Location and Competitors
Table 54. Zealand Pharma Short Bowel Syndrome (SBS) Major Business
Table 55. Zealand Pharma Short Bowel Syndrome (SBS) Total Revenue (USD Million) (2017-2018)
Table 56. Zealand Pharma SWOT Analysis
Table 57. Zealand Pharma Short Bowel Syndrome (SBS) Product and Solutions
Table 58. Zealand Pharma Short Bowel Syndrome (SBS) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Short Bowel Syndrome (SBS) Revenue (Million USD) by Players (2015-2020)
Table 60. Global Short Bowel Syndrome (SBS) Revenue Share by Players (2015-2020)
Table 61. Global Short Bowel Syndrome (SBS) Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Short Bowel Syndrome (SBS) Revenue Market Share by Regions (2015-2020)
Table 63. North America Short Bowel Syndrome (SBS) Revenue by Countries (2015-2020)
Table 64. North America Short Bowel Syndrome (SBS) Revenue Market Share by Countries (2015-2020)
Table 65. Europe Short Bowel Syndrome (SBS) Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Short Bowel Syndrome (SBS) Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Short Bowel Syndrome (SBS) Revenue by Countries (2015-2020)
Table 68. South America Short Bowel Syndrome (SBS) Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Short Bowel Syndrome (SBS) Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Short Bowel Syndrome (SBS) Revenue Market Share by Countries (2015-2020)
Table 71. Global Short Bowel Syndrome (SBS) Revenue (Million USD) by Type (2015-2020)
Table 72. Global Short Bowel Syndrome (SBS) Revenue Share by Type (2015-2020)
Table 73. Global Short Bowel Syndrome (SBS) Revenue Forecast by Type (2021-2025)
Table 74. Global Short Bowel Syndrome (SBS) Revenue by Application (2015-2020)
Table 75. Global Short Bowel Syndrome (SBS) Revenue Share by Application (2015-2020)
Table 76. Global Short Bowel Syndrome (SBS) Revenue Forecast by Application (2021-2025)
Table 77. Global Short Bowel Syndrome (SBS) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Short Bowel Syndrome (SBS) Picture
Figure 2. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type in 2019
Figure 3. Oral Route Picture
Figure 4. Parental Route Picture
Figure 5. Short Bowel Syndrome (SBS) Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Global Short Bowel Syndrome (SBS) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Short Bowel Syndrome (SBS) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Short Bowel Syndrome (SBS) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Short Bowel Syndrome (SBS) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Short Bowel Syndrome (SBS) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Short Bowel Syndrome (SBS) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Short Bowel Syndrome (SBS) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Short Bowel Syndrome (SBS) Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Short Bowel Syndrome (SBS) Revenue Market Share in 2019
Figure 18. Global Top 10 Players Short Bowel Syndrome (SBS) Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Short Bowel Syndrome (SBS) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Short Bowel Syndrome (SBS) Revenue Market Share by Regions (2015-2020)
Figure 22. Global Short Bowel Syndrome (SBS) Revenue Market Share by Regions in 2018
Figure 23. North America Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 24. Europe Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 26. South America Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 28. North America Short Bowel Syndrome (SBS) Revenue Market Share by Countries (2015-2020)
Figure 29. North America Short Bowel Syndrome (SBS) Revenue Market Share by Countries in 2019
Figure 30. USA Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 31. Canada Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 33. Europe Short Bowel Syndrome (SBS) Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Short Bowel Syndrome (SBS) Revenue Market Share by Countries in 2019
Figure 35. Germany Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 36. UK Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 37. France Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 38. Russia Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 39. Italy Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Short Bowel Syndrome (SBS) Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Short Bowel Syndrome (SBS) Revenue Market Share by Countries in 2019
Figure 42. China Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 43. Japan Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 44. Korea Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 45. India Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 47. South America Short Bowel Syndrome (SBS) Revenue Market Share by Countries (2015-2020)
Figure 48. South America Short Bowel Syndrome (SBS) Revenue Market Share by Countries in 2019
Figure 49. Brazil Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Short Bowel Syndrome (SBS) Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Short Bowel Syndrome (SBS) Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 54. UAE Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Short Bowel Syndrome (SBS) Revenue and Growth Rate (2015-2020)
Figure 57. Global Short Bowel Syndrome (SBS) Revenue Share by Type (2015-2020)
Figure 58. Global Short Bowel Syndrome (SBS) Revenue Share by Type in 2019
Figure 59. Global Short Bowel Syndrome (SBS) Market Share Forecast by Type (2021-2025)
Figure 60. Global Oral Route Revenue Growth Rate (2015-2020)
Figure 61. Global Parental Route Revenue Growth Rate (2015-2020)
Figure 62. Global Short Bowel Syndrome (SBS) Revenue Share by Application (2015-2020)
Figure 63. Global Short Bowel Syndrome (SBS) Revenue Share by Application in 2019
Figure 64. Global Short Bowel Syndrome (SBS) Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Clinics Revenue Growth Rate (2015-2020)
Figure 67. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 68. Global Short Bowel Syndrome (SBS) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Short Bowel Syndrome (SBS) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Short Bowel Syndrome (SBS) Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Short Bowel Syndrome (SBS) Revenue Market Forecast (2021-2025)
Figure 72. Europe Short Bowel Syndrome (SBS) Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Short Bowel Syndrome (SBS) Revenue Market Forecast (2021-2025)
Figure 74. South America Short Bowel Syndrome (SBS) Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Short Bowel Syndrome (SBS) Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
短腸症候群（SBS）の世界市場（～2026年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…- 短腸症候群の世界市場（～2026年） Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition…
- 短腸症候群（SBS）治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Short Bowel Syndrome (SBS) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Short Bowel …
- 短腸症候群（SBS）治療薬の世界市場（～2026年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
- 炎症性腸疾患（IBD）治療の世界市場（～2026年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…